Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Co-codamol 30/500 Tablets Found In One Batch of Wockhardt Co-codamol 8/500 Tablets
The Medicines and Healthcare Products Regulatory Agency (MHRA) has received reports of rogue higher strength Co-codamol 30/500 tablets in blisters of one batch of the lower strength 8/500 Wockhardt brand tablets. The affected batch number is LL11701 and the pack size is 32 tablets. The 8/500 tablets are marked on one side only as " < AB > " and are unmarked on the other side, while the rogue higher strength tablets are marked on one side as ‘CCD30’ and as "CP" on the other. Healthcare professionals are being asked to contact patients and to return any remaining stock of the affected batch. Co-codamol contains a combination of paracetamol and codeine and is used to control pain. It is available in a variety of strengths of codeine but only the preparation made by Wockhardt which contains 8mg codeine and 500mg paracetamol is affected by this alert. For more information please visit: http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON146826
Learn More

Marketing Authorisation For Teva Brand Levothyroxine 100mcg Tablets Suspended Over Effectiveness Concerns
The Medicines and Healthcare products Regulatory Agency (MHRA) has suspended the marketing authorisation for levothyroxine 100mcg tablets manufactured by Teva. This comes after reports that this brand of levothyroxine was less effective than other brands, as well as evidence of manufacturing difficulties. As a precautionary measure Teva has stopped manufacturing and distributing levothyroxine 100mcg tablets whilst investigations are ongoing. Only the Teva and Numark brands of this product are affected by the suspension and other brands continue to be available. Healthcare professionals have been advised to be alert to any changes in the symptoms of patients who take levothyroxine, as this may be due to them taking the Teva brand of tablets. Levothyroxine is a replacement for a hormone that is normally produced by the thyroid gland to regulate the body's energy and metabolism. It is given when the thyroid gland does not produce enough of this hormone on its own. For more information please visit: http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON146528
Learn More

Date Published Title Medicine Source
2012-03-26 Co-codamol 30/500 Tablets Found In One Batch of Wockhardt Co-codamol 8/500 Tablets Paracetamol/Codeine MHRA
2012-03-19 Marketing Authorisation For Teva Brand Levothyroxine 100mcg Tablets Suspended Over Effectiveness Concerns Levothyroxine Sodium MHRA
2012-03-09 Study Links Vitamin E Supplement to Thinning of the Bones in Rodents Vitamin E MediGuard CRT
2012-03-09 Results of New Study Suggests Some Parents Are Unaware of Proper Use of Paracetamol Medised MediGuard CRT
2012-03-07 Dosing Pipette Changed in Two Batches of Epistatus Buccal Liquid Midazolam MHRA
2012-03-06 Healthcare Professionals Advised to Not Use Aliskiren-Containing Medicines in Combination with Angiotensin Converting Enzyme inhibitors or Angiotensin Receptor Blockers Aliskiren Manufacturer
2012-03-06 Precautions Highlighted For Safer Use Of Ketoprofen Gel Ketoprofen MHRA
2012-02-21 European Medicines Agency Confirms Positive Benefit-Risk Balance of Orlistat Orlistat EMEA
2012-02-09 Proton Pump Inhibitors Linked to Small Increase in Hip Fracture Risk in Post-Menopausal Women Omeprazole MediGuard CRT
2012-02-09 Teva Recalls Single Batch of Alendronic Acid 10mg Tablets Due to Concerns Regarding Stability Alendronic Acid MHRA
2012-02-02 Pioglitazone Safety Information Updated Due to a Small Increased Risk of Developing Bladder Cancer Pioglitazone and Metformin MHRA
2012-02-02 Heart Function Should be Monitored when Starting Treatment with Gilenya Fingolimod MHRA
2012-01-26 Reckitt Benckiser Recalls Two Batches of 500ml Gaviscon Advance Aniseed Suspension Due To Solidification of Contents Peptac MHRA
2012-01-24 MHRA Warns Allergy Sufferers That Dekristol Contains Peanut Oil and Vigantoletten Contains Soya Oil Colecalciferol MHRA
2012-01-23 Meprobamate To Be Withdrawn From The European Market EMEA
2012-01-23 Meprobamate To Be Withdrawn From The European Market Meprobamate EMEA
2012-01-20 SSRIs Linked to Increased Risk of Falls in Elderly Patients with Dementia Paroxetine MediGuard CRT
2012-01-18 Labelling Error Results in Recall of a Single Batch of Amoxicillin Capsules Made by Accord Healthcare Amoxicillin MHRA
2012-01-18 Bacterial Contamination Leads to Recall of Sterimar Isotonic Nasal Spray Sterimar MHRA
2012-01-16 Statins Linked to Raised Blood Sugar and Diabetes in Some Patients Simvastatin MHRA